Atlas Trials

Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

Clinical trial NCT07139353 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07139353
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Peripheral T Cells Lymphoma (PTCL)
Start date
2025-09-15
Primary completion
2027-09-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.